Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HALO - Halozyme: Steady Revenue Growth At A Reasonable Valuation

HALO - Halozyme: Steady Revenue Growth At A Reasonable Valuation

Halozyme Therapeutics Inc.
  • I was drawn to Halozyme due to its business model that is devoid of in-house drug development. Halozyme reformulates many blockbuster drugs that provided them with significant milestones and royalty.
  • What is more, the impressive number of partners diversifies their revenue sources and clinical success.
  • The company’s growth trends have remained intact throughout the pandemic and are projected to endure several more years.
  • Now, I am moving HALO into my “Top Ideas” list considering the company's recent earnings and commercial success.

For further details see:

Halozyme: Steady Revenue Growth At A Reasonable Valuation
Stock Information
Company Name: Halozyme Therapeutics Inc.
Stock Symbol: HALO
Market: NASDAQ
Website: halozyme.com
Menu
HALO HALO Quote HALO Short HALO News HALO Articles HALO Message Board
Get HALO Alerts

News, Short Squeeze, Breakout and More Instantly...